Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study

European Journal of Pain (United Kingdom)

Volumn 18, Issue 5, 2014, Pages 671-679

  Maihofner C G ^a   Heskamp, M L S ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Astellas Pharma GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; ANALGESIC AGENT;

ADULT; APPLICATION SITE ERYTHEMA; APPLICATION SITE PAIN; ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPATHIC PAIN; NUMERIC PAIN RATING SCALE; PAIN ASSESSMENT; PERIPHERAL NEUROPATHIC PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT DURATION; TREATMENT RESPONSE; AGED; CLINICAL TRIAL; CONTROLLED STUDY; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PROSPECTIVE STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANALGESICS; CAPSAICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84898978302     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2013.00415.x     Document Type: Article

References (29)

1. Backonja, M.M., Irving, G., Webster, L., Tobias, J., Vanhove, G., (2011). Efficacy of NGX-4010, a prescription strength capsaicin 8% patch for the treatment of postherpetic neuralgia, across a range of patient populations. Neurology 76 (9, S4), A110.
2. Brown, S., Simpson, D.M., Moyle, G., Brew, B., Schifitto, G., Larbalestier, N., Orkin, C., Fisher, M., Vanhove, G.F., Tobias, J.K., (2013). NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: Integrated analysis of two phase III, randomized, controlled trials. AIDS Res Ther 10, 5.
3. Burgmer, M., Pfleiderer, B., Maihofner, C., Gaubitz, M., Wessolleck, E., Heuft, G., Pogatzki-Zahn, E., (2012). Cerebral mechanisms of experimental hyperalgesia in fibromyalgia. Eur J Pain 16, 636-647.
4. Cochrane-Glossar (2013). Das Deutsche Cochrane Zentrum. Available at: http://www.cochrane.de/de/cochrane-glossar (Accessed 14 June 2013).
5. Deumens, R., Steyaert, A., Forget, P., Schubert, M., Lavand'homme, P., Hermans, E., De Kock, M., (2013). Prevention of chronic postoperative pain: Cellular, molecular, and clinical insights for mechanism-based treatment approaches. Prog Neurobiol 104, 1-37.
6. Dickinson, B.D., Head, C.A., Gitlow, S., Osbahr, A.J., (2010). Maldynia: Pathophysiology and management of neuropathic and maladaptive pain-a report of the AMA Council on Science and Public Health. Pain Med 11, 1635-1653.
7. Frettloh, J., Maier, C., Gockel, H., Zenz, M., Huppe, M., (2009). Characterization of chronic pain patients in German pain centers: Core data from more than 10,000 patients. Schmerz 23, 576-591.
8. Gandek, B., Ware, J.E., Aaronson, N.K., Apolone, G., Bjorner, J.B., Brazier, J.E., Bullinger, M., Kaasa, S., Leplege, A., Prieto, L., Sullivan, M., (1998). Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51, 1171-1178.
9. Gerbershagen, H.J., (2013). Transition from acute to chronic postsurgical pain. Physiology, risk factors and prevention. Schmerz 27, 81-96.
10. Hasenbring, M., Hallner, D., Klasen, B., (2001). Psychological mechanisms in the transition from acute to chronic pain: Over- or underrated? Schmerz 15, 442-447.
11. von Hehn, C.A., Baron, R., Woolf, C.J., (2012). Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 73, 638-652.
12. Hughes, R.A.C., (2002). Peripheral neuropathy. BMJ 324, 466-469.
13. Huppe, M., Maier, C., Gockel, H., Zenz, M., Frettloh, J., (2011). Success of treatment in higher stages of pain chronification as well? An evaluation of the Mainz pain staging system based on the QUAST-analysis sample. Schmerz 25, 77-88.
14. Lynch, M.E., Campbell, F., Clark, A.J., Dunbar, M.J., Goldstein, D., Peng, P., Stinson, J., Tupper, H., (2008). A systematic review of the effect of waiting for treatment for chronic pain. Pain 136, 97-116.
15. Maihofner, C., Heskamp, M.-L., (2013). Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain. First results of the QUEPP study. Curr Med Res Opin 29, 673-683.
16. Marchettini, P., Lacerenza, M., Mauri, E., Marangoni, C., (2006). Painful peripheral neuropathies. Curr Neuropharmacol 4, 175-181.
17. Moye, L.A., (2012). Rudiments of subgroup analyses. Prog Cardiovasc Dis 54, 338-342.
18. National Institute for Health and Care Excellence (2010). Neuropathic Pain-Pharmacological Management. (CG96). Available at: http://www.nice.org.uk/ guidance/CG96 (Accessed 14 June 2013).
19. Nickel, F.T., Seifert, F., Lanz, S., Maihoefner, C., (2012). Mechanisms of neuropathic pain. Eur Neuropsychopharmacol 22, 81-91.
20. Novak, C.B., Anastakis, D.J., Beaton, D.E., Katz, J., (2009). Patient-reported outcome after peripheral nerve injury. J Hand Surg Am 34, 281-287.
21. O'Connor, A.B., Dworkin, R.H., (2009). Treatment of neuropathic pain: An overview of recent guidelines. Am J Med 122, S22-S32.
22. Portenoy, R.K., Duma, C., Foley, K.M., (1986). Acute herpetic and postherpetic neuralgia: Clinical review and current management. Ann Neurol 20, 651-664.
23. Seifert, F., Maihoefner, C., (2011). Functional and structural imaging of pain-induced neuroplasticity. Curr Opin Anaesthesiol 24, 515-523.
24. Stammschulte, T., Pachl, H., Gundert-Remy, U., Luetkehermoelle, W., Paeschke, N., Volz-Zang, C., Keller-Stanislawski, B., (2010). Einführung in die Grundlagen der Pharmakovigilanz (Teil II): Spontanmeldesystem zur Erfassung von Verdachtsfällen unerwünschter Arzneimittelwirkungen (UAW). Bulletin zur Arzneimittelsicherheit. Informationen aus BfArM und PEI 4/2010: 18-26.
25. Turk, D.C., Audette, J., Levy, R.M., Mackey, S.C., Stanos, S., (2010). Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain. Mayo Clin Proc 85, S42-S50.
26. Ultsch, B., Koster, I., Reinhold, T., Siedler, A., Krause, G., Icks, A., Schubert, I., Wichmann, O., (2012). Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ. doi: 10.1007/s10198-012- 0452-1.
27. VfA (2010). VFA NIS Datenbank. NIS Database of the Research-based Pharmaceutical Companies in Germany. Available at: http://www.vfa.de/de/ arzneimittel-forschung/datenbanken-zu-arzneimitteln/nisdb/nis-details/-599.
28. Wang, R., Lagakos, S.W., Ware, J.H., Hunter, D.J., Drazen, J.M., (2007). Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med 357, 2189-2194.
29. Woolf, C.J., (2011). Central sensitization: Implications for the diagnosis and treatment of pain. Pain 152, S2-S15.